Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction
Cells · 12.04.2025 · 14 (8) · 583
DOI: 10.3390/cells14080583 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 12.04.2025. Verfasst von Ye Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Modern Fermentation Engineering and Future Foods, School of Light Industry and Food Engineering, Guangxi University, No. 100, Daxuedong …. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Tumor Suppressor Protein p53, Proto-Oncogene Proteins, Nuclear Proteins. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Province.
Abstract (Originalsprache)
p53 is a tumor suppressor gene and is regarded as one of the most crucial genes in protecting humans against cancer. The protein Mdm2 and its homolog MdmX serve as negative regulators of p53. In nearly half of cancer cells, there is an overexpression of Mdm2 and MdmX, which inhibit p53 activity. Furthermore, Mdm2’s E3 ubiquitin ligase activity promotes the ubiquitination and degradation of p53. Therefore, blocking the interaction between p53 and Mdm2/MdmX to prevent the degradation of wild-type p53 is an effective strategy for inhibiting tumor growth. This paper primarily discusses the regulatory relationship between p53, MdmX and Mdm2, and provides a review of the current status of p53-Mdm2/MdmX inhibitors. It aims to offer a theoretical foundation and research direction for the future discovery and design of targeted inhibitors against the p53-Mdm2/MdmX interaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Modern Fermentation Engineering and Future Foods, School of Light Industry and Food Engineering, Guangxi University, No. 100, Daxuedong Road, Nanning 530004, China.
- School of Pharmaceutical Sciences and Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
ORCID-Profile: Zhengding Su, Xiyao Cheng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
Zitieren
APA
Huang, Y., Li, W., Zhou, Y., Bai, J., Li, N., Su, Z., & Cheng, X. (2025). Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction. Cells, 14(8), 583. https://doi.org/10.3390/cells14080583
Vancouver
Huang Y, Li W, Zhou Y, Bai J, Li N, Su Z, et al. Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction. Cells. 2025;14(8):583. doi:10.3390/cells14080583
BibTeX
@article{Huang2025,
author = {Huang, Ye and Li, Wang and Zhou, Yuke and Bai, Jinping and Li, Ning and Su, Zhengding and Cheng, Xiyao},
title = {Strategies for p53 Activation and Targeted Inhibitors of the p53-Mdm2/MdmX Interaction},
journal = {Cells},
year = {2025},
volume = {14},
number = {8},
pages = {583},
doi = {10.3390/cells14080583}
}
EUVIMED